TATA健康国际控股有限公司（01255）8月17日公告，公司董事会已排期于2026年8月28日（星期五）召开会议，议程包括：一、审议及批准集团截至2026年6月30日止六个月之未经审计综合中期业绩；二、酌情考虑派付中期股息（如有）；三、处理其他事项。
公告显示，截至公告日，董事会由六名成员组成，其中执行董事一名——张鸣琪先生；非执行董事一名——陈琦先生；独立非执行董事四名——黄琳女士、李亮先生、杜建峰先生及谭开国先生。
公司提醒投资者，相关业绩及分红方案须待董事会正式审议及批准后方能确定，具体结果以后续公告为准。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.